肝细胞癌切除术后复发的多学科治疗现状与展望

摘要/Abstract

摘要： 手术切除是肝细胞癌最主要的根治性治疗手段，但术后复发率高，且最常见于肝内复发。合理有效的治疗复发性肝癌，能够进一步提高肝癌患者的长期生存率。目前主要有手术再切除、肝移植、局部消融治疗、介入治疗、靶向治疗以及全身化疗等治疗手段应用于复发性肝癌的治疗。由于复发性肝癌病情多较为复杂，临床上常采用多种方法的联合或者序贯治疗，本文就肝细胞癌切除术后复发的多学科治疗做一综述。

关键词: 肝细胞癌, 复发, 肝切除术, 消融治疗, 综合治疗

Abstract: Hepatectomy remains the main radical treatment for hepatocellular carcinoma (HCC), but the recurrences after surgery is frequent and most of them are intrahepatic recurrences. Effective treatment for recurrent tumors can prolong the long-term survival. There are many therapeutic methods, including re-hepatectomy, liver transplantation, local ablation, transcatheter arterial chemoembolization (TACE), molecular target therapy and systemic chemotherapy, available now for recurrent tumors. However multi-disciplinary treatment or combined treatments are always needed for these tumors. In present paper, the current status and prospect of multi-disciplinary treatment for recurrent HCC are reviewed.

Key words: Hepatocellular carcinoma, Recurrence, Hepatectomy, Ablation, Multi-disciplinary treatment

中图分类号:

R735.7

张耀军(综述)，陈敏山(审校). 肝细胞癌切除术后复发的多学科治疗现状与展望[J]. 外科研究与新技术, 2013, 2(4): 255-258.

ZHANG Yao-jun, CHEN Min-shan. Multi-disciplinary treatment for recurrent hepatocellular carcinoma after hepatectomy:current status and prospect[J]. Surgical Research and New Technique, 2013, 2(4): 255-258.

参考文献

[1]Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma [J].Lancet,2012,379(9822):1245-1255.
[2] Ercolani G,Grazi GL,Ravaioli M,et al.Liver resection for hepatocellular carcinoma on cirrhosis:univariate and multivariate analysis of risk factors for intrahepatic recurrence [J].Ann Surg,2003,237(4):536-43.
[3] Matsuda M,Fujii H,Kono H,et al.Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence:repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer [J].J Hepatobiliary Pancreat Surg,2001,8(4):353- 359.
[4] Poon RT,Fan ST,Lo CM,et al.Intrahepatic recurrence after curative resection of hepatocellular carcinoma:long-term results of treatment and prognostic factors [J].Ann Surg,1999,229(2):216-222.
[5] Minagawa M,Makuuchi M,Takayama T,Kokudo N:Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma [J].Ann Surg,2003,238(5):703-710.
[6] Wu CC,Cheng SB,Yeh DC,et al.Second and third hepatectomies for recurrent hepatocellular carcinoma are justified [J].Br J Surg,2009,96(9):1049-1057.
[7] Zhou Y,Sui C,Li B,et al.Repeat hepatectomy for recurrent hepatocellular carcinoma:a local experience and a systematic review [J].World J Surg Oncol,2010,8(7):55.
[8] Hwang S,Lee SG,Moon DB,et al.Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma [J].Liver Transpl,2007,13(5):741.
[9] Vennarecci G,Ettorre GM,Antonini M,et al.First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma [J].Transplant Proc,2007,39(6):1857.
[10] Kim BW,Park YK,Kim YB,et al.Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection:feasibility of the Milan criteria and operative risk [J].Transplant Proc,2008,40(10):3558-3561.
[11] Li HY,Wei YG,Yan LN,et al.Salvage liver transplantation in the treatment of hepatocellular carcinoma:A Meta-analysis [J].World J Gastroenterol,2012,18(19):2415-2422.
[12] Choi JW,Park JY,Ahn SH,et al.Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection [J].Am J Clin Oncol,2009,32(6):564-549.
[13] Chen MS,Li JQ,Zheng Y,et al.A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J].Ann Surg,2006,243(3):321-8.
[14] Peng ZW,Lin XJ,Zhang YJet al.Radiofrequency ablation vs.hepatic resection for the treatment of hepatocellular carcinomas smaller than 2 cm.A retrospective comparative study [J].Radiology,2012,262(3):1022-1033.
[15] Taura K,Ikai I,Hatano E,et al.Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection:an analysis of 610 patients over 16 years old [J].Ann Surg,2006,244(2):265-273.
[16] Choi D,Lim HK,Rhim H,etal.Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy:long-term results and prognostic factors [J].Ann Surg Oncol,2007,14(8):2319-2329.
[17] Liang HH,Chen MS,Peng ZW,et al.Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma:a retrospective study [J].Ann Surg Oncol,2008,15(12):3484-3493.
[18] Ho CM,Lee PH,Shau WY,et al.Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy:comparative effectiveness of treatment modalities [J].Surgery,2012,151(5):700-709.
[19] Zhang YJ,Liang HH,Chen MS,et al.Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection:a prospective randomized trial [J].Radiology,2007,244(2):599-607.
[20] Zhao JD,Xu ZY,Zhu J,et al.Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma:the feasibility and benefit [J].Radiother Oncol,2008,87(3):439-444.
[21] Huang WY,Jen YM,Lee MS,et al.Stereotactic Body Radiation Therapy in Recurrent Hepatocellular Carcinoma [J].Int J Radiat Oncol Biol Phys,2012,84(2):355-361.
[22] Llovet JM,Ricci S,Mazzaferro V,et al.Sorafenib in advanced hepatocellular carcinoma [J].N Engl J Med,2008,359(4):378-390.
[23] Cheng AL,Kang YK,Chen Z,et al.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma:a phase III randomised,double-blind,placebo-controlled trial [J].Lancet Oncol,2009,10 (1):25-34.
[24] Peng ZW,Zhang YJ,Liang HH,et al.Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone:a prospective randomized trial [J].Radiology,2012,262(2):689-700.
[25] Peng ZW,Zhang YJ,Chen MS,et al.Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma:a prospective randomized trial [J].J Clin Oncol,2013,31(4):426-432.